Patents by Inventor Bartholomew Weldon

Bartholomew Weldon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230241102
    Abstract: The present invention generally relates to liquid compositions and methods for treating oral inflammation by administering a liquid composition to the oral cavity. The liquid composition is prepared from a powder containing calcium glycerophosphate, one or more sodium phosphate salts, sodium chloride, and optionally sodium bicarbonate and silica. The powder is mixed with a quality of water to form a liquid that is supersaturated with calcium ions and phosphate ions and is essentially free of visible particles and precipitate.
    Type: Application
    Filed: February 24, 2023
    Publication date: August 3, 2023
    Inventors: Bartholomew Weldon, Edward Kobus, Sandryne Dumoulin, Aimesther Betancourt, Patrick Gosselin
  • Patent number: 11590165
    Abstract: The present invention generally relates to liquid compositions and methods for treating oral inflammation by administering a liquid composition to the oral cavity. The liquid composition is prepared from a powder containing calcium glycerophosphate, one or more sodium phosphate salts, sodium chloride, and optionally sodium bicarbonate and silica. The powder is mixed with a quality of water to form a liquid that is supersaturated with calcium ions and phosphate ions and is essentially free of visible particles and precipitate.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: February 28, 2023
    Assignee: BAUSCH HEALTH COMPANIES INC.
    Inventors: Bartholomew Weldon, Edward Kobus, Sandryne Dumoulin, Aimesther Betancourt, Patrick Gosselin
  • Patent number: 9433644
    Abstract: The present invention generally relates to formulations and methods for treating oral inflammation, oral injury and/or oral pain by applying hydrogel, viscous liquid, or other formulation to the oral cavity. Wet formulations comprise a hydrophilic polymer selected from the group consisting of pyrrolidones, hyaluronic acid and salts thereof, alginic acid and salts thereof, and carrageenans and salts thereof; calcium salts or ions, phosphate salts or ions, and water as well as other optional components. Dry formulations such as powders are also contemplated.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: September 6, 2016
    Assignee: Rutgilli Pharmaceuticals, LLC
    Inventors: Edward D. Kobus, Bartholomew Weldon
  • Publication number: 20160175356
    Abstract: The present invention generally relates to liquid compositions and methods for treating oral inflammation by administering a liquid composition to the oral cavity. The liquid composition is prepared from a powder containing calcium glycerophosphate, one or more sodium phosphate salts, sodium chloride, and optionally sodium bicarbonate and silica. The powder is mixed with a quality of water to form a liquid that is supersaturated with calcium ions and phosphate ions and is essentially free of visible particles and precipitate.
    Type: Application
    Filed: November 19, 2015
    Publication date: June 23, 2016
    Inventors: Bartholomew Weldon, Edward Kobus, Sandryne Dumoulin, Aimesther Betancourt, Patrick Gosselin
  • Publication number: 20150030694
    Abstract: The present invention generally relates to formulations and methods for treating oral inflammation, oral injury and/or oral pain by applying hydrogel, viscous liquid, or other formulation to the oral cavity. Wet formulations comprise a hydrophilic polymer selected from the group consisting of pyrrolidones, hyaluronic acid and salts thereof, alginic acid and salts thereof, and carrageenans and salts thereof; calcium salts or ions, phosphate salts or ions, and water as well as other optional components. Dry formulations such as powders are also contemplated.
    Type: Application
    Filed: July 24, 2014
    Publication date: January 29, 2015
    Inventors: Edward D. Kobus, Bartholomew Weldon
  • Publication number: 20110086108
    Abstract: This invention involves the formulation of stable powders which, when dissolved in water form a non-pressurized carbonated solution supersaturated with calcium and phosphate ions, and also containing the presence of carbon dioxide and sodium bicarbonate. The resulting solution is used as an oral rinse for the prevention and treatment of inflammatory processes of the soft tissues of the mouth, throat and oral cavity, which may result from infection or trauma to the oral mucosal tissue.
    Type: Application
    Filed: October 26, 2009
    Publication date: April 14, 2011
    Inventor: Bartholomew Weldon